Invasive cancers | |||
---|---|---|---|
40-49 | 50-69 | Total | |
Screening to assessment | |||
≤ 5 wd | 40 (87.0%) | 86 (92.5%) | 126 (90.6%) |
6-10 wd | 3 (6.5%) | 3 (3.2%) | 6 (4.3%) |
> 10 wd | 3 (6.5%) | 4 (4.3%) | 7 (5.0%) |
Decision to operate to date of therapy | |||
≤ 10 wd | 42 (93.3%) | 73 (83.9%) | 115 (87.1%) |
11-15 wd | 1 (2.2%) | 3 (3.4%) | 4 (3.0%) |
16-30 wd | 1 (2.2%) | 4 (4.6%) | 5 (3.8%) |
> 30 wd | 1 (2.2%) | 7 (8.0%) | 8 (6.1%) |
All screens except those ending in invasive cancers | |||
40-49 | 50-69 | Total | |
Screening to assessment | |||
≤ 5 wd | 162 (72.3%) | 166 (75.1%) | 328 (73.7%) |
6-10 wd | 17 (7.6%) | 24 (10.9%) | 41 (9.2%) |
> 10 wd | 45 (20.1%) | 31 (14.0%) | 76 (17.1%) |